Below is our list of additional helpful on vaccination! We’ve collected these resources from reputable resources and hope you can find them useful when recommending vaccines.
Trainings on Childhood Immunization
Title of Training(Date Published) |
Length of Time |
Topics Included |
Format |
Continuing education credit offered? +deadline |
| Protecting infants from RSV (10/26/2023) | 60 mins. |
RSV vaccine epidemiology in children, efficacy, safety, recommendations, and updates
|
Webinar |
|
| Current Issues in Immunization – “2024 Updates to the Child/Adolescent and Adult Immunization Schedules” (3/6/2024) | 55 mins. |
Overview of vaccine schedule, 2024 updates, vaccination resources for healthcare providers
|
Webinar |
|
| Strengthening Vaccine Confidence: Refreshing our Conversations about Child and Adolescent Vaccinations (5/4/2023) | 57 mins. |
Challenges related to COVID-19 pandemic, vaccine hesitancy/confidence, improving vaccination access as a preventive public health measure, new conversations on childhood vaccinations
|
Webinar | N/A |
| Improving COVID-19 Vaccination Rates for Children 6 months through 5 years of age (N/A) | N/A | This free online CME uses case scenarios to help you implement the latest guidance and updates from the Advisory Committee on Immunization Practices (ACIP). It also addresses culturally relevant information you need to effectively educate hesitant parents, especially those in ethnic and racial groups at increased risk for associated morbidity and mortality. | Online CME |
|
| RSV and Nirsevimab Recommendations Webinar (2/1/2024) | 60 mins. |
Nirsevimab recommendations, supply and ordering updates, and tips for effectively answering questions about nirsevimab
|
Webinar |
|
Trainings on Prenatal Vaccination
Title of Training(Date Published) |
Length of Time |
Topics Included |
Format |
Continuing education credit offered? +deadline |
| Clinical Vaccination Guidance for Pregnant People (8/10/2023) | 58 mins. | Maternal vaccination recommendations, safety, coverage, RSV updates, tips for making a strong recommendations and additional resources | Webinar |
|
| Current Issues in Vaccines- Fall 2023 – “RSV Vaccines Across the Lifespan” (9/13/2023) | N/A |
Overview of vaccine schedule, 2024 updates, vaccination resources for healthcare providers
|
|
Additional Trainings on Vaccination
Title of Training(Date Published) |
Length of Time |
Topics Included |
Format |
Continuing education credit offered? +deadline |
| Principles of Vaccination (7/1/2022) | 49 mins. | Emerging immunization issues, identify routine immunizations, characteristics, resources, implement disease detection and prevention services | Webinar |
|
| General Best Practice Guidelines Pt.1 (7/12/2022) | 55 mins. |
Immunization timing, precautions, preventing and managing adverse reactions, storage, information sources
|
Webinar |
|
| General Best Practice Guidelines Pt.2 and Vaccine Safety (7/19/2022) | 44 mins. |
Screening questions, vaccine safety, VAERS, Vaccine Safety Datalink, Clinical Immunization Safety Assessment (CISA)
|
Webinar |
|
| Immunization Strategies (7/26/2022) | 32 mins. |
Vaccine coverage, strategies, barriers to immunization, recommendations and how to start vaccine conversations
|
Webinar |
|
| DTaP/Tdap (8/9/2022) | 57 mins. |
Clinical features of Diphtheria, Tetanus, and Pertussis. Clinical considerations, adverse reactions, precautions
|
Webinar |
|
| Rotavirus and Hepatitis A (8/16/2022) | 48 mins. |
Rotavirus and Hep A disease information, clinical features, epidemiology, complications, vaccine schedule and recommendations
|
Webinar |
|
| Meningococcal Vaccines (8/23/2022) | 43 mins. |
Neisseria meningitidis disease information, clinical features, meningococcal meningitis, risk factors, vaccine schedule and recommendations
|
Webinar |
|
| Measles, Mumps, Rubella (8/30/2022) | 61 mins. |
Measles, mumps, and rubella disease information, complications, epidemiology, MMR vaccine information, serologic testing, and schedule for all ages
|
Webinar |
|
| Varicella (9/13/2022) | 46 mins. |
Varicella disease information, clinical features, epidemiology, vaccine information, recommendations, and adverse reactions
|
Webinar |
|
| Zoster (9/20/2022) | 33 mins. |
Zoster disease information, clinical features, complications, epidemiology, vaccine information and recommendations, adverse reactions
|
Webinar |
|
| Hepatitis B (9/27/2022) | 49 mins. |
Hepatitis B disease information, clinical features, phases of infection, vaccine information and recommendations
|
Webinar |
|
| HPV (10/4/2022) | 40 mins. |
HPV disease information, clinical features, epidemiology, vaccine information including efficacy and safety, vaccine scheduling and recommendations
|
Webinar |
|
| Pneumococcal Vaccines (10/11/2022) | 37 mins. |
Streptococcus pneumoniae information, pneumococcal disease information, risk factors, vaccine information, scheduling, recommendations, and adverse reactions
|
Webinar |
|
| Influenza (10/18/2022) | 34 mins |
Influenza disease information, clinical features, complications, epidemiology, efficacy and effectiveness of seasonal influenza vaccine, recommendations and scheduling
|
Webinar |
|
| Dengue (11/1/2022) | 30 mins. |
Dengue disease information, epidemiology, clinical features, vaccine information and recommendations, laboratory testing requirements, vaccine adverse reactions
|
Webinar |
|
| COVID-19 (5/11/2023) | 60 mins. |
Vaccine policy updates, vaccine dosage, vulnerable populations, implications of new recommendations, implications for vaccine providers, recommendations by age and immunocompromised status
|
Webinar |
|
| We Must Maintain Measles Elimination in the United States: Measles Clinical Presentation, Diagnosis, and Prevention (8/17/2023) | 63 mins. |
Clinical presentation of measles, surveillance, epidemiology, laboratory diagnosis, vaccination recommendations and dosage, contraindications, vaccine adverse reactions, prevention, resources for clinicians
|
Webinar |
|
| Current Issues in Vaccines – Winter 2023 – “Making the broadest, long-lasting COVID-19 Vaccine” (12/6/2023) | N/A |
mRNA vaccines: Pfizer, Moderna, vaccine effectiveness, omicron variant, t-cells, studies, and the future of COVID-19 vaccines
|
pdf – presentation slides |
|